Martin Hossann

1.7k total citations
28 papers, 1.4k citations indexed

About

Martin Hossann is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Martin Hossann has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Biomaterials, 14 papers in Molecular Biology and 11 papers in Biomedical Engineering. Recurrent topics in Martin Hossann's work include Nanoparticle-Based Drug Delivery (20 papers), RNA Interference and Gene Delivery (10 papers) and Lipid Membrane Structure and Behavior (8 papers). Martin Hossann is often cited by papers focused on Nanoparticle-Based Drug Delivery (20 papers), RNA Interference and Gene Delivery (10 papers) and Lipid Membrane Structure and Behavior (8 papers). Martin Hossann collaborates with scholars based in Germany, Netherlands and France. Martin Hossann's co-authors include Lars H. Lindner, Michael Peller, Gerhard Winter, Rolf D. Issels, Hansjörg Eibl, Kirsten Wachholz, Gerben A. Koning, Timo L.M. ten Hagen, Michael Wiggenhorn and Gerard C. van Rhoon and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Martin Hossann

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Martin Hossann

Since Specialization

Citations

This map shows the geographic impact of Martin Hossann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hossann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hossann more than expected).

Fields of papers citing papers by Martin Hossann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hossann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hossann. The network helps show where Martin Hossann may publish in the future.

Co-authorship network of co-authors of Martin Hossann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hossann. A scholar is included among the top collaborators of Martin Hossann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hossann. Martin Hossann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Local drug delivery of irinotecan with phosphatidyldiglycerol-based thermosensitive liposomes reduces systemic exposure and increases therapeutic efficacy compared to systemic drug and Onivyde® 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), Gerhard Winter, Lars H. Lindner, Martin Hossann	0
2	Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or Excipients 2023 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Michael Paal, Katharina Habler, (unknown), Martin Hossann, Gerhard Winter, Lars H. Lindner	3
3	Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model 2022 ·Journal of Controlled Release ·(unknown), (unknown), Edwin Heijman, (unknown), (unknown), Sandra N. Ekdawi, (unknown), (unknown), (unknown), (unknown), Sin Yuin Yeo, (unknown), Christina Lucas, Susanne Brodesser, Martin Hossann, Lars H. Lindner, Holger Grüll	28
4	Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes 2021 ·International Journal of Nanomedicine ·(unknown), (unknown), (unknown), Martin Hossann, Olivia M. Merkel, Lars H. Lindner	33
5	Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study 2021 ·Journal of Controlled Release ·(unknown), (unknown), Alisa Kleinhempel, (unknown), Patricia M. Schwarz, Martin Hossann, Lesca M. Holdt, Volker Mailänder, Lars H. Lindner	15
6	Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomes 2021 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Michael Paal, (unknown), (unknown), Martin Hossann, Michael Vogeser, Gerhard Winter, Lars H. Lindner	4
7	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer 2021 ·International Journal of Nanomedicine ·F. Johannes P. van Valenberg, Iris Brummelhuis, Lars H. Lindner, (unknown), (unknown), P Schweizer, Martin Hossann, J. Alfred Witjes, Egbert Oosterwijk	24
8	Impact of plasma protein binding on cargo release by thermosensitive liposomes probed by fluorescence correlation spectroscopy 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Judith J. Mittag, (unknown), (unknown), Martin Hossann, Gerhard Winter, Stefan Wuttke, Hanna Engelke, Joachim O. Rädler	22
9	Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors 2015 ·Journal of Controlled Release ·(unknown), (unknown), Martin Hossann, (unknown), Kirsten Wachholz, Timo L.M. ten Hagen, Gerben A. Koning, Ronald Sroka, Lars H. Lindner, Michael Peller	49
10	Thermosensitive liposomal drug delivery systems: state of the art review 2014 ·International Journal of Nanomedicine ·Martin Hossann, (unknown), Michael Peller, Lars H. Lindner, Gerhard Winter	278
11	Nanomedicine-based strategies for treatment of atherosclerosis 2014 ·Trends in Molecular Medicine ·Maximilian Schiener, Martin Hossann, Joana R. Viola, Almudena Ortega‐Gómez, Christian Weber, Kirsten Lauber, Lars H. Lindner, Oliver Soehnlein	74
12	Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy 2013 ·Journal of Controlled Release ·Li Li, Timo L.M. ten Hagen, Martin Hossann, Regine Süss, Gerard C. van Rhoon, Alexander Eggermont, Dieter Haemmerich, Gerben A. Koning	170
13	Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomes 2012 ·Journal of Controlled Release ·Martin Hossann, Tungte Wang, Zulfiya Syunyaeva, Michael Wiggenhorn, (unknown), Rolf D. Issels, Maximilian F. Reiser, Lars H. Lindner, Michael Peller	26
14	Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes 2012 ·Journal of Controlled Release ·Martin Hossann, Zulfiya Syunyaeva, (unknown), (unknown), Hansjörg Eibl, Rolf D. Issels, Lars H. Lindner	69
15	Size of thermosensitive liposomes influences content release 2010 ·Journal of Controlled Release ·Martin Hossann, Tungte Wang, Michael Wiggenhorn, (unknown), (unknown), Gerhard Winter, Hansjörg Eibl, Michael Peller, Maximilian F. Reiser, Rolf D. Issels, Lars H. Lindner	92
16	In vitro characterization of phosphatidylglyceroglycerol‐based thermosensitive liposomes with encapsulated ¹H MR T₁‐shortening gadodiamide 2008 ·Contrast Media & Molecular Imaging ·Tungte Wang, Martin Hossann, Herbert M. Reinl, Michael Peller, Hansjoerg Eibl, Maximilian Reiser, Rolf D. Issels, Lars H. Lindner	23
17	MR Characterization of Mild Hyperthermia-Induced Gadodiamide Release From Thermosensitive Liposomes in Solid Tumors 2008 ·Investigative Radiology ·Michael Peller, (unknown), Martin Hossann, Herbert M. Reinl, Tungte Wang, Steven Sourbron, Manfred Ogris, Lars H. Lindner	38
18	In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes 2007 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Martin Hossann, Michael Wiggenhorn, (unknown), Kirsten Wachholz, (unknown), Hansjörg Eibl, Rolf D. Issels, Lars H. Lindner	110
19	Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release 2007 ·Journal of Controlled Release ·Lars H. Lindner, Martin Hossann, Michael Vogeser, (unknown), Kirsten Wachholz, Hansjoerg Eibl, Wolfgang Hiddemann, Rolf D. Issels	60
20	On the contentious sequence and glycosylation motif of the ribosome inactivating plant protein gelonin 2005 ·Biochemical and Biophysical Research Communications ·(unknown), Martin Hossann, Wolfgang E. Trommer, Gereon Niedner‐Schatteburg	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact